www.stiripesurse.ro/cancerul-de-san-ar-putea-fi-de

An international research team has developed a blood test that detects early-stage breast cancer and predicts recurrence risk after treatment. This breakthrough, announced by the Weizmann Institute of Science, could enhance cancer detection and monitoring. The test identifies tiny traces of cancer cells in blood by analyzing chemical markers. In trials with diagnosed women and healthy participants, it achieved a 95% accuracy rate for early detection. Researchers also found aggressive cancer cells that can survive treatment, aiding in recurrence prediction with 81% accuracy. This technology may help doctors identify high-risk patients and tailor appropriate treatments.